Leaders in Supply & Demand Side Intelligence

Forgot your login?

Enter the e-mail address you used when you registered an account with IIR Energy.

A message will be sent to the E-Mail Address found in our records containing the associated username(s) as well as instructions for a password reset.

E-Mail:

Johnson & Johnson Secures Global Manufacturing Capacity for COVID-19 Hopeful, an Industrial Info Market Brief

Free News Article
JJ
Attachment Included

Fueled by a global pandemic and hundreds of millions of federal WARP SPEED dollars, Johnson & Johnson (J&J) is locking down a global manufacturing network to launch production if its COVID-19 vaccine candidate gets the regulatory green light. From Baltimore, Maryland, to Leiden, Netherlands, the pharma giant has expanded beyond its own already substantial means to partner with contract development manufacturing organizations (CDMOs) Emergent and Catalent.

It is important to note that many of the sites are either in the midst of an expansion or already have substantial capacity in place and will be expanding to 24/7 shifts. Industrial Info is tracking a combined 111 plants and 103 projects belonging to these companies. Click here for a list of plants and here for a list of projects. See map below.

Details on this Article:
Industry Segment: Market Brief
Word Count: 136 Words
Attachment: JJ
Listen to Today's News News Audio Library Sync News Podcasts

Login or Register now for instant access!
Related Articles

FREE ARTICLE

This article is free for all Registered Members.

Register Now! All Fields are Required...



Pricing Help?

Upgrade your Premium News Subscription to include all archived articles for only $160. Contact Member Services: 800-762-3361

All Members Receive the Following Free Resources:

  • North American Project & Gap Spending
  • North American Plant Analysis by Industry & Market Region
  • Market Maps & Stats - Capital & Maintenance Activity
  • Current & Historic Economic Indicators
  • 30/60/90 Day Weather Forecast